Description

Nobivac^® Canine 1-DAPPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus. 

Nobivac^® Lepto₄ bacterin is recommended for the vaccination of healthy dogs as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa.

Dosage and Administration

Shake the Nobivac^® Lepto₄ vial and transfer its contents to the Nobivac^® Canine 1-DAPPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Inject one dose (1 mL) subcutaneously. The initial dose may be given at 8 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. 


Nobivac Canine 1-DAPPv+L4 is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

Click here for our Vaccine Shipping Schedule.